Suven Pharma

Suven Pharmaceuticals Ltd Balance Sheet

NSEBSE

₹985.4

(0.51%)

Sep 15, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Suven Pharmaceuticals Ltd

FINANCIALS

Profit & Loss Balance Sheet Cash Flow Ratios Results

ConsolidatedStandalone

GraphTable

Y/e 31 Mar( In .Cr)	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Equity Capital	25.46	25.46	25.46	25.46
Preference Capital	0	0	0	0
Reserves	2,290.09	2,002.89	1,723.92	1,495.24
Net Worth	2,315.55	2,028.35	1,749.38	1,520.7
Minority Interest
Debt	98.64	65.01	70.34	97.12
Deferred Tax Liability Net	56.82	58.92	43.05	38.87
Total Liabilities	2,471.01	2,152.28	1,862.77	1,656.69
Fixed Assets	938.72	848.7	676.84	564.19
Intangible Assets
Investments	1,116.2	892.57	710.06	599.9
Deferred Tax Asset Net	22.03	11.59	1.4	1.47
Networking Capital	371.44	377.69	428.24	458.19
Inventories	154.12	231.2	311.47	283.42
Inventory Days				78.35
Sundry Debtors	242.47	133.66	109.66	236.37
Debtor Days				65.34
Other Current Assets	113.68	86.21	104.07	88.07
Sundry Creditors	-77.63	-46.19	-74.4	-107.44
Creditor Days				29.7
Other Current Liabilities	-61.2	-27.19	-22.56	-42.23
Cash	22.62	21.73	46.23	32.95
Total Assets	2,471.01	2,152.28	1,862.77	1,656.7

Suven Pharma : related Articles

Suven Pharma Q3 Profit Jumps 77% YoY, Revenue Up 40%

Revenue from operations of the company stood at ₹307.2 crore, with a Year-on-Year (YoY) growth of 39.8% quarter over Q3 FY24 as compared to ₹219.8 crore

13 Feb 2025|03:10 PM